logo
Blog
  • eSource DDC
  • eCOA
  • ePRO
  • eConsent
  • BYOD
  • |
  • Back to clinicalink.com
ePRO / eCOA / CNS

Making Data Central to Your CNS and Pain Trials: A Therapeutic-Area-Specific Approach to Data Capture Solutions

A year or two ago, the team at Clinical Ink noticed a lot of growth in CNS and pain trials. These trials are demanding from a data capture standpoint: complicated eligibility criteria, extensive monitoring requirements, comprehensive data collection, and substantial demands on patients all must be overcome.

Read More
Gena Gough Gena Gough September 28, 2020

Subscribe to Email Updates

Filter By Category

  • BYOD (2)
  • CNS (1)
  • eCOA (12)
  • eConsent (2)
  • ePRO (11)
  • eSource DDC (5)
  • Gastrointestinal (1)
  • Infectious Disease (2)
  • Lupus (3)
  • Oncology (1)

Filter By Author

  • Doug Pierce (7)
  • Ed Seguine (3)
  • Gena Gough (2)
  • Jonathan Andrus (5)
  • Tess Dugan (1)

Popular Articles

ePRO / eCOA

Mixed-Modality Deployment Compatible With Any Trial Design

Lupus / eCOA

Happy Site, Happy Life: Illuminate the Path to a Brighter Future for Lupus Research by Easing Site Workflows

More From Clinical Ink

Screen Shot 2020-12-15 at 10.23.01 AM-1 Fact Sheet

Virtual Trials: Trust in Experience, Trust in Lunexis™

ClinicalInk_WhitePaper_GI_7-7-20_VF_Cover-1 White Paper

Improve GI Data and Patient Engagement With GI ePRO/eCOA

Clinical-Ink_Successful-BYOD_screenshot White Paper

Successful BYOD in Any Phase

More Articles

All posts

About Clinical Ink

Clinical Ink, a global clinical technology company, offers data certainty from source to submission via our Lunexis™ eSource clinical technology and configurable direct data capture (DDC), eCOA, ePRO, and eConsent modules. This suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source naturally enhances clinical trial workflows. For virtual, traditional, or hybrid trials, Lunexis technology reduces manual labor and provides anytime, anywhere data access, saving resources as your trials progress. For more information, visit clinicalink.com.